Black Diamond Therapeutics
Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with genetically defined cancers driven by oncogenes activated by allosteric mutations.
Cambridge, Massachusetts, USA
New York, New York, USA
Stony Brook, New York, USA
Toronto, Ontario, Canada
Investment Stage: IPO January 2020